[177Lu]Lu-DOTA-TATE clinical trials
3 indexed studies · 1 currently recruiting
- Active not recruitingPHASE1
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
This study looks at new ways to treat prostate cancer that has spread. It uses special scans to find cancer cells and then delivers targeted radiation therapy to those cells, aiming to see how well it works and if it's safe.
For: Metastatic Neuroendocrine Prostate CancerUnited States · France · Germany - RecruitingPHASE3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
This study looks at a new treatment for certain types of advanced bowel and pancreatic cancers (GEP-NETs). It compares a combination of a new drug ([177Lu]Lu-DOTA-TATE) and an existing one (Octreotide LAR) to Octreotide LAR alone, checking how well it works and if it's safe.
For: Somatostatin Receptor Positive (SSTR+) · Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)United States · Canada · China - Active not recruitingPHASE1, PHASE2
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
This study is testing a new combination treatment for a type of lung cancer called Extensive Stage Small Cell Lung Cancer (ES-SCLC). It aims to find a safe dose and see if this new combination works better than current treatments for people newly diagnosed with this aggressive cancer.
For: Extensive Stage Small Cell Lung CancerUnited States · Austria · Canada